Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 4 | 1 |
| List of Figures | 5 | 1 |
| AMAG Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
| AMAG Pharmaceuticals, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 | 7 | 1 |
| AMAG Pharmaceuticals, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
| AMAG Pharmaceuticals, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 | 9 | 1 |
| AMAG Pharmaceuticals, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 | 10 | 1 |
| AMAG Pharmaceuticals, Inc., Medical Equipment, Deal Details | 11 | 13 |
| Private Equity | 11 | 1 |
| MSMB Capital Management To Acquire AMAG Pharma | 11 | 1 |
| Partnerships | 12 | 1 |
| Cesca Therapeutics Amends Licensing Agreement with CBR Systems | 12 | 1 |
| Access Pharma Enters Into Licensing Agreement With Amag Pharma For MuGard | 13 | 2 |
| Equity Offering | 15 | 1 |
| AMAG Pharma Raises USD231 Million in Public Offering of Shares | 15 | 2 |
| Amag Pharma Files Registration Statement For Public Offering Of Securities For Up To US$250 Million | 17 | 1 |
| AMAG Pharma Completes Public Offering Of US$174 Million | 18 | 2 |
| Debt Offering | 20 | 1 |
| AMAG Pharma Raises USD500 Million in Private Placement of 7.878% Notes Due 2023 | 20 | 1 |
| Amag Pharma Completes Public Offering Of Notes Due 2019 For US$200 Million | 21 | 2 |
| Acquisition | 23 | 1 |
| AMAG Pharma Plans For Sale Of The Company | 23 | 1 |
| AMAG Pharmaceuticals, Inc. - Key Competitors | 24 | 1 |
| Key Employees | 25 | 2 |
| Locations And Subsidiaries | 27 | 1 |
| Head Office | 27 | 1 |
| Other Locations &Subsidiaries | 27 | 1 |
| Recent Developments | 28 | 1 |
| Financial Announcements | 28 | 1 |
| Aug 09, 2016: AMAG Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update | 28 | 3 |
| May 03, 2016: AMAG Pharmaceuticals Reports First Quarter 2016 Financial Results | 31 | 2 |
| Feb 17, 2016: AMAG Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Financial Results | 33 | 2 |
| Jul 23, 2015: AMAG Pharmaceuticals Reports Record Second Quarter 2015 Financial Results | 35 | 2 |
| May 05, 2015: AMAG Pharmaceuticals Reports Record First Quarter 2015 Financial Results and Increases Financial Guidance | 37 | 2 |
| Feb 09, 2015: AMAG Announces Final Fourth Quarter and Year End 2014 Financial Results | 39 | 2 |
| Jan 11, 2015: AMAG Pharmaceuticals Provides Business Update and 2015 Financial Guidance | 41 | 2 |
| Corporate Communications | 43 | 1 |
| Sep 07, 2016: AMAG Pharmaceuticals Appoints Tony Casciano as Senior Vice President of Hematology/Oncology Sales and Marketing | 43 | 1 |
| Jul 12, 2016: AMAG Pharmaceuticals Appoints Mark Stanton as Vice President, Market Access &Corporate Accounts | 44 | 1 |
| Apr 11, 2016: AMAG Pharmaceuticals Appoints Edward Myles as Chief Financial Officer | 45 | 1 |
| Jan 04, 2016: AMAG Pharmaceuticals Appoints Nicholas Grund as Chief Commercial Officer | 46 | 1 |
| Aug 24, 2015: AMAG Pharmaceuticals Appoints Joseph Vittiglio as General Counsel and Secretary | 47 | 1 |
| Jun 09, 2015: AMAG Pharmaceuticals Appoints Aaron Pelta as Vice President of Business Development | 48 | 1 |
| Jun 02, 2015: AMAG Pharmaceuticals Announces New Senior Management Appointments | 49 | 1 |
| Apr 01, 2015: AMAG Pharmaceuticals Announces New Management Appointments | 50 | 1 |
| Other Significant Developments | 51 | 1 |
| Jul 15, 2016: PhRMA Welcomes Five New Member Companies | 51 | 1 |
| Jan 11, 2016: AMAG Pharmaceuticals Announces Preliminary 2015 Financial Results and Provides 2016 Financial Guidance | 52 | 1 |
| Appendix | 53 | 1 |
| Methodology | 53 | 1 |
| About GlobalData | 53 | 1 |
| Contact Us | 53 | 1 |
| Disclaimer | 53 | 1 |